Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2872 |  OVID Ovid Therapeutics Inc. - Common Stock | 2.71 USD | -3.21% | -3.90% | +15.32% | +146.36% | 529.26 M USD | ||
| 2883 |  ARTV Artiva Biotherapeutics, Inc. - Common Stock | 10.81 USD | -1.10% | -5.18% | +8.21% | +159.86% | 528.50 M USD | ||
| 2889 |  CABA Cabaletta Bio, Inc. - Common Stock | 3.13 USD | 0.00% | +14.65% | +13.82% | +90.85% | 530.68 M USD | ||
| 2891 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 6.28 USD | -5.28% | +11.94% | +61.86% | +390.63% | 501.17 M USD | ||
| 2899 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.10 USD | -3.80% | -1.82% | +8.58% | +107.69% | 500.93 M USD | ||
| 2900 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 10.78 USD | -3.84% | -7.15% | -15.85% | -43.26% | 499.95 M USD | ||
| 2915 |  EVMN Evommune, Inc. Common Stock | 13.20 USD | -5.58% | -9.71% | +17.75% | -23.79% | 479.06 M USD | ||
| 2928 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.43 USD | -4.32% | -6.93% | -14.31% | +603.17% | 472.55 M USD | ||
| 2930 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.84 USD | -4.00% | -7.25% | +12.61% | +48.26% | 472.42 M USD | ||
| 2934 |  RZLT Rezolute, Inc. - Common Stock | 4.82 USD | -5.30% | +4.56% | -2.63% | -31.14% | 464.13 M USD | ||
| 2944 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.58 USD | -1.86% | +19.70% | +3.27% | -24.04% | 477.67 M USD | ||
| 2947 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.26 USD | -2.01% | +5.47% | +4.28% | +5.71% | 475.38 M USD | ||
| 2956 |  EDIT Editas Medicine, Inc. - Common Stock | 3.05 USD | -1.93% | +8.54% | +15.97% | +8.16% | 468.42 M USD | ||
| 2957 |  PBYI Puma Biotechnology Inc - Common Stock | 9.03 USD | -2.27% | +1.35% | +12.31% | +70.38% | 466.13 M USD | ||
| 2962 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 7.00 USD | -5.28% | +4.79% | -7.53% | -21.17% | 450.38 M USD | ||
| 2970 |  OCGN Ocugen, Inc. - Common Stock | 1.33 USD | -4.32% | -0.75% | +6.40% | +31.68% | 451.02 M USD | ||
| 2983 |  BNTC Benitec Biopharma Inc. - Common Stock | 13.46 USD | -0.15% | +7.51% | +16.03% | -18.96% | 462.41 M USD | ||
| 2991 |  EYPT EyePoint, Inc. - Common Stock | 5.11 USD | -3.95% | +21.96% | -59.05% | -57.42% | 440.54 M USD | ||
| 2999 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 12.91 USD | -2.57% | -3.73% | +2.79% | -12.18% | 441.10 M USD | ||
| 3024 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.30 USD | -2.39% | +3.11% | +11.11% | +65.11% | 425.08 M USD |
Nachrichten Biotechnology Stocks
Deutsche Bank stuft Argenx Aktie wegen Bewertung auf ’Hold’ herab
Klinischer Meilenstein ohne Kursschub: Aktie von Monte Rosa Therapeutics unter Druck
Biomea Fusion Aktie mit Kurssprung nach Abschluss der Rekrutierung für Diabetes-Studie
Monte Rosa Aktie fällt nach Start von Phase-2-Studie zu Prostatakrebs
ROUNDUP/Aktien New York: Chipwerte belasten Nasdaq kräftig - Dow leicht im Plus
Crinetics Pharmaceuticals Aktie erreicht Allzeithoch bei 84,8 USD
H.C. Wainwright bekräftigt "Buy"-Rating für Biomea Fusion nach Meilenstein in Diabetes-Studie
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |